Dr. Gilligan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-9060Fax+1 617-264-6841
Education & Training
- Massachusetts General HospitalFellowship, Pain Medicine, 2007 - 2008
- Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical SchoolResidency, Emergency Medicine, 2004 - 2007
- Brigham and Women's HospitalResidency, Surgery, 1997 - 2004
- New York Presbyterian Hospital (Cornell Campus)Internship, Surgery, 1996 - 1997
- Yale School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 1998 - 2025
- FL State Medical License 2016 - 2018
- American Board of Emergency Medicine Emergency Medicine
- American Board of Emergency Medicine Pain Medicine
Clinical Trials
- ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain Start of enrollment: 2016 Aug 01
- Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults Start of enrollment: 2018 Oct 16
- Long-Term Follow-up Safety of Clonidine Micropellets Start of enrollment: 2018 Nov 15
Publications & Presentations
PubMed
- Fatty infiltration of the erector spinae.Alaa Abd-Elsayed, Christopher Gilligan
Pain Practice. 2024-11-01 - Reduction in opioid consumption and improvement in function with spinal cord stimulation.Alaa Abd-Elsayed, Christopher Gilligan
Pain Practice. 2024-11-01 - Elevated lead impedances in spinal cord stimulation systems.Alaa Abd-Elsayed, Christopher Gilligan
Pain Practice. 2024-09-12
Press Mentions
- Effect of Antiseptic Irrigation with 0.05% Chlorhexidine Gluconate (Irrisept) on the Incidence of Cutibacterium Acnes in Primary Shoulder ArthroplastyNovember 16th, 2024
- Five-Year Longitudinal Follow-up of Restorative Neurostimulation Shows Durability of Effectiveness in Patients with Refractory Chronic Low Back Pain Associated with Multifidus Muscle DysfunctionSeptember 3rd, 2024
- New Guidelines for Cannabis in Chronic Pain Management ReleasedApril 7th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: